Eupraxia Pharmaceuticals (EPRX)
NASDAQ:EPRX

Eupraxia Pharmaceuticals (EPRX) Technical Analysis

2 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
5Neutral
13Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Eupraxia Pharmaceuticals’s (EPRX) Moving Averages Convergence Divergence (MACD) indicator is -0.01, suggesting Eupraxia Pharmaceuticals is a Sell.
Eupraxia Pharmaceuticals’s (EPRX) 20-Day exponential moving average is 2.63, while Eupraxia Pharmaceuticals’s (EPRX) share price is $2.61, making it a Sell.
Eupraxia Pharmaceuticals’s (EPRX) 50-Day exponential moving average is 2.73, while Eupraxia Pharmaceuticals’s (EPRX) share price is $2.61, making it a Sell.

Eupraxia Pharmaceuticals (EPRX) Pivot Points

Jul 28, 2024, 05:08 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.67
2.69
2.75
2.77
2.83
2.85
2.91
Fibonacci
2.69
2.72
2.74
2.77
2.80
2.82
2.85
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Eupraxia Pharmaceuticals (EPRX) Moving Averages

Jul 28, 2024, 05:08 PM
Period
Simple
Exponential
MA5
2.62Sell
2.64Sell
MA10
2.63Sell
2.63Sell
MA20
2.62Sell
2.63Sell
MA50
2.70Sell
2.73Sell
MA100
2.92Sell
3.02Sell
MA200
3.61Sell
3.62Sell
Eupraxia Pharmaceuticals’s (EPRX) 10-Day exponential moving average is 2.63, while Eupraxia Pharmaceuticals’s (EPRX) share price is $2.61, making it a Sell.
Eupraxia Pharmaceuticals’s (EPRX) 100-Day exponential moving average is 3.02, while Eupraxia Pharmaceuticals’s (EPRX) share price is $2.61, making it a Sell.
Eupraxia Pharmaceuticals’s (EPRX) stock price is $2.61 and Eupraxia Pharmaceuticals’s (EPRX) 50-day simple moving average is 2.70, creating a Sell signal.
Eupraxia Pharmaceuticals’s (EPRX) stock price is $2.61 and Eupraxia Pharmaceuticals’s (EPRX) 100-day simple moving average is 2.92, creating a Sell signal.
Eupraxia Pharmaceuticals’s (EPRX) stock price is $2.61 and Eupraxia Pharmaceuticals’s (EPRX) 200-day simple moving average is 3.61, creating a Sell signal.

Eupraxia Pharmaceuticals (EPRX) Technical Indicators

Jul 28, 2024, 05:08 PM
Name
Value
Implied Action
RSI (14)
48.59
Neutral
STOCH (9,6)
51.37
Neutral
STOCHRSI (14)
50.41
Neutral
MACD (12,26)
-0.01
Sell
ADX (14)
18.79
Buy
Williams %R
-63.41
Buy
CCI (14)
0.38
Neutral
ATR (14)
0.19
-
Ultimate Oscillator
39.36
Neutral
ROC
4.40
Buy
Eupraxia Pharmaceuticals’s (EPRX) Relative Strength Index (RSI) is 48.59, creating a Neutral signal.
Eupraxia Pharmaceuticals’s (EPRX) Trend Strength Indicator (ADX) is 18.79, creating a Buy signal.
Eupraxia Pharmaceuticals’s (EPRX) Commodity Channel Index (CCI) is 0.38, creating a Neutral signal.
Eupraxia Pharmaceuticals’s (EPRX) Price Rate of Change (ROC) is 4.40, creating a Buy signal.

FAQ

Is EPRX a Buy, Hold, or Sell?
Based on EPRX’s technical indicators, EPRX is a Sell.
    What is EPRX’s RSI (14)?
    EPRX’s RSI (14) is 48.59, which suggests EPRX is a Neutral.
      What is EPRX’s MACD?
      EPRX’s MACD is -0.01, which suggests EPRX is a Sell.
        What is EPRX’s 5-day moving average?
        EPRX’s 5-day moving average is 2.62, which suggests EPRX is a Sell.
          What is EPRX’s 20-day moving average?
          EPRX 20-day moving average is 2.62, which suggests EPRX is a Sell.
            What is EPRX’s 50-day moving average?
            EPRX’s 50-day moving average is 2.70, which suggests EPRX is a Sell.
              What is EPRX’s 200-day moving average?
              EPRX’s 200-day moving average is 3.61, which suggests EPRX is a Sell.
                What is EPRX’s Williams % R (14)?
                EPRX’s Williams % R (14) is -63.41, which suggests EPRX is a Buy.
                  What is EPRX’s CCI (14)?
                  EPRX’s CCI (14) is 0.38, which suggests EPRX is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis